Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling in the Intensive Care Unit

Sponsor
Fresno Community Hospital and Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT03554811
Collaborator
Western University of Health Sciences (Other)
32
1
2
48
0.7

Study Details

Study Description

Brief Summary

Critically ill patients in the intensive care unit are known to lose muscle mass and function at a rapid rate. Currently, there is a global recognition and shift in the ICU culture to reduce sedation and encourage exercise and mobilization early during the ICU stay. Functional stimulation assisted supine cycling can be applied to patients in the bed and does not require patient participation. This study seeks to evaluate the effect of conventional exercise and early mobilization in combination with functional stimulation assisted supine cycling applied early during the ICU on muscle mass, strength, and physical function, as well as patient-reported disability as compared to conventional exercise and early mobilization alone.

Condition or Disease Intervention/Treatment Phase
  • Device: Functional electrical stimulation assisted supine cycling (FESC)
  • Other: Conventional early exercise and mobility interventions
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling Effect on Muscle Mass, Strength, Biomarkers, and Functional Outcomes as Compared With Conventional Exercise and Early Mobilization Alone in Critically Ill Patients in the Intensive Care Unit
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Functional electrical stimulation assisted supine cycling

Patients will start functional electrical stimulation assisted supine cycling (FESC) within 48 hours of ICU admission and will undergo up to 1 hour of supine cycling daily, 5 days per week for 28 days, or until discharge from ICU.

Device: Functional electrical stimulation assisted supine cycling (FESC)
A supine cycle ergometer attached to a six-channel stimulator will be used for FESC. Surface electrodes will be applied to the hamstrings, quadriceps, and calf muscles on both legs. Muscles will be stimulated at specific stages throughout the cycling phase. Each session will start with a 1 minute motor-driven passive cycling warm-up at a rate of 20 revolutions per minute. Patients will continue with passive, active-assisted, or active cycling, according to their level of participation. If the patients stop cycling actively, the ergometer will revert to passive cycling.

Other: Conventional early exercise and mobility interventions
These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.

Active Comparator: Conventional early exercise and mobility interventions

Patients will undergo standard ICU exercise and mobility interventions.

Other: Conventional early exercise and mobility interventions
These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.

Outcome Measures

Primary Outcome Measures

  1. Percent change of rectus femoris cross-sectional area [Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Ultrasound measurements will be done with patients in supine position with their leg in passive extension and neutral rotation.

Secondary Outcome Measures

  1. Diaphragm muscle thickness [Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Thickness will be measured by ultrasound at the zone of apposition during inspiration or expiration using the intercostal approach.

  2. Muscle strength [Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge]

    Muscle strength will be assessed using the Medical Research Council Scale. This muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle. Weaker muscles will range from 0-3 and stronger muscles will receive grades 4 or 5.

  3. Muscle strength [Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge]

    Muscle strength will be assessed using hand-held dynamometry

  4. Physical function [Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Physical function will be assessed using the physical function in ICU (PFIT) test

  5. Physical function [Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Physical function will be assessed using the functional status score in the ICU (FSS-ICU). This score consists of 3 pre-ambulation categories (rolling; supine to sit transfer; and unsupported sitting) and 2 ambulation categories (sit to stand transfers; ambulation). Each category is scored from 1 (total dependent assistance) to 7 (complete independence) with a total score range of 0-35 (0: unable to perform a task due to physical limitations or medical status).

  6. Physical function [Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Physical function will be assessed using the short physical performance battery (SPPB)

  7. Physical function [Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)]

    Physical function will be assessed using the six-minute walk test (6MWT)

  8. Quality of life [At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge]

    Quality of life will be measured using the 36-item Short Health Survey (SF-36), which assess eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each item is scored on a 0-100 scale and items in the same category are averaged together to create the 8 scale scores, with 0 being the lowest score and 100 being the highest for each category.

  9. Cognition [At hospital discharge (an average of 15 days after admission)]

    Cognition will be assessed using the Montreal Cognitive Assessment (MoCA).

  10. Hospital length of stay [Through hospital discharge, an average of 15 days]

    The total hospital length of stay for this admission will be calculated.

  11. ICU length of stay [Through ICU discharge, an average of 11 days]

    The total ICU length of stay for this admission will be calculated.

  12. Duration of mechanical ventilation [Through discontinuation of mechanical ventilation, an average of 10 days]

    The total length of time on mechanical ventilation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ≥ 18 years of age

  • Admitted to the ICU with a predicted ICU length of stay ≥ 4 days

  • Expected to survive the ICU stay

  • Expected to receive mechanical ventilation > 48 hours

  • Able to perform physical outcome measures pre-morbidly (with or without an assisted device)

Exclusion Criteria:
  • Proven or suspected neuromuscular weakness affecting the legs (eg- stroke or Guillain-Barré syndrome)

  • Lower limb amputation(s)

  • Assessed by medical staff as approaching imminent death or withdrawal of medical treatment within 36 hours

  • Pregnancy

  • Body mass index > 40

  • Presence of external fixator or superficial metal in lower limb

  • Open wounds or skin abrasions at electrode application points

  • Presence of pacemaker or implanted defibrillator

  • Transferred from another ICU after >48 hours of consecutive mechanical ventilation

  • Lower limb malignancy

  • Pre-existing intellectual disability or cognitive impairment limiting the ability to accurately follow instructions

  • Body habitus unable to fit the bike

  • Palliative goals of care

  • Unable to participate in FESC within 48 hours of ICU admission due to logistic reasons or due to failure in daily screening for participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Community Regional Medical Center Fresno California United States 93721

Sponsors and Collaborators

  • Fresno Community Hospital and Medical Center
  • Western University of Health Sciences

Investigators

  • Principal Investigator: Paul D Smith, PT, DPT, Community Medical Centers

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fresno Community Hospital and Medical Center
ClinicalTrials.gov Identifier:
NCT03554811
Other Study ID Numbers:
  • 2018015
First Posted:
Jun 13, 2018
Last Update Posted:
Aug 20, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Aug 20, 2021